7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer’s Disease Treatment. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.